Privia Health Group, Inc. (PRVA)

Privia Health Group Stock Forecast

Stock Price Forecast

The 14 analysts with 12-month price forecasts for Privia Health Group stock have an average target of 27.57, with a low estimate of 20 and a high estimate of 40. The average target predicts an increase of 10.02% from the current stock price of 25.06.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$20	$27.57	$28	$40
Change	-20.19%	+10.02%	+11.73%	+59.62%

Analyst Ratings

The average analyst rating for Privia Health Group stock from 14 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '24	Jan '25	Feb '25	Mar '25	Apr '25	May '25
Strong Buy	4	6	6	6	5	4
Buy	7	8	10	9	9	9
Hold	2	2	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	13	16	17	16	15	14

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Constantine Davides JMP Securities	JMP Securities	Buy Reiterates $29	Buy	Reiterates	$29	+15.72%	Apr 28, 2025
Michael Ha Baird	Baird	Buy Maintains $24 → $26	Buy	Maintains	$24 → $26	+3.75%	Apr 15, 2025
Andrew Mok Barclays	Barclays	Hold Maintains $21 → $23	Hold	Maintains	$21 → $23	-8.22%	Apr 10, 2025
Jailendra Singh Truist Securities	Truist Securities	Strong Buy Maintains $27 → $28	Strong Buy	Maintains	$27 → $28	+11.73%	Apr 10, 2025
Matthew Sheerin Needham	Needham	Strong Buy Reiterates $30	Strong Buy	Reiterates	$30	+19.71%	Apr 10, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

3.28B

Increased by 88.96%

from 1.74B

Revenue Next Year

3.63B

Increased by 10.70%

from 3.28B

EPS This Year

0.25

Increased by 129.34%

from 0.11

EPS Next Year

0.38

Increased by 51.13%

from 0.25

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	817.08M	966.22M	1.36B	1.66B	1.74B	3.28B	3.63B	4.05B
Revenue Growth	3.91%	18.25%	40.41%	22.19%	4.75%	88.96%	10.70%	11.45%
EPS	0.33	-1.83	-0.08	0.19	0.11	0.25	0.38	0.47
EPS Growth	278.92%	-	-	-	-42.11%	129.34%	51.13%	22.61%
Forward PE	-	-	-	-	-	99.34	65.73	53.60
No. Analysts	-	-	-	-	-	25	23	12

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	3.4B	3.9B	4.5B
Avg	3.3B	3.6B	4.0B
Low	3.1B	3.4B	3.7B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	96.2%	17.8%	23.7%
Avg	89.0%	10.7%	11.5%
Low	79.7%	4.1%	1.5%

EPS Forecast

EPS	2025	2026	2027
High	0.39	0.84	0.64
Avg	0.25	0.38	0.47
Low	0.18	0.27	0.39

EPS Growth

EPS Growth	2025	2026	2027
High	253.2%	233.0%	68.0%
Avg	129.3%	51.1%	22.6%
Low	60.4%	8.8%	2.8%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.